We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Correction clarifies integration of transcriptomics and proteomics for assessing antisense oligonucleotide safety and efficacy.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: